Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/16/2026, 3:27:31 AM
    Content snapshot
    {
      "session_id": "sess_SDA-2026-04-15-gap-pubmed-20260411-093843-0a9326c2_20260416-032731",
      "round_number": 4,
      "agent_persona": "persona-synthesizer",
      "agent_backend": "minimax/MiniMax-M2.7",
      "action": "synthesize",
      "content": "\n\n{\n  \"ranked_hypotheses\": [\n    {\n      \"rank\": 1,\n      \"title\": \"BACE1-dependent NRG1 Type III cleavage controls Node of Ranvier stability and saltatory conduction\",\n      \"mechanism\": \"BACE1 constitutively cleaves neuregulin-1 (NRG1) type III at the axonal membrane to generate EGF-like signals required for paranodal junction maintenance and voltage-gated sodium channel clustering.\",\n      \"target_gene\": \"NRG1\",\n      \"confidence_score\": 0.75,\n      \"novelty_score\": 0.5,\n      \"feasibility_score\": 0.45,\n      \"impact_score\": 0.85,\n      \"composite_score\": 0.68,\n      \"testable_prediction\": \"Conditional BACE1 deletion in adult Schwann cells (post-development) will cause progressive nodal instability and conduction deficits, distinguishing maintenance from developmental requirements.\",\n      \"skeptic_concern\": \"Critically unresolved whether nodal maintenance requires continuous BACE1 activity or whether developmental absence simply persists as a static phenotype in adult animals.\"\n    },\n    {\n      \"rank\": 2,\n      \"title\": \"BACE1 mediates activity-dependent synaptic processing critical for cognitive function\",\n      \"mechanism\": \"BACE1 is regulated by neuronal activity and cleaves synaptic substrates (including neuregulins and other targets) required for acute synaptic plasticity, explaining rapid cognitive worsening within weeks of inhibitor administration.\",\n      \"target_gene\": \"BACE1\",\n      \"confidence_score\": 0.65,\n      \"novelty_score\": 0.55,\n      \"feasibility_score\": 0.6,\n      \"impact_score\": 0.8,\n      \"composite_score\": 0.66,\n      \"testable_prediction\": \"Acute BACE1 inhibition in adult mice will cause rapid deficits in synaptic plasticity (LTP/ LTD) independent of developmental effects, testable within 2-4 weeks of treatment.\",\n      \"skeptic_concern\": \"Identifying the precise synaptic BACE1 substrates mediating these acute cognitive effects remains challenging; activity-dependent regulation may be compensatory rather than essential.\"\n    },\n    {\n      \"rank\": 3,\n      \"title\": \"BACE1 inhibition increases seizure risk through impaired axonal maintenance and network hyperexcitability\",\n      \"mechanism\": \"Combined disruption of nodal stability and synaptic function creates a permissive environment for network hyperexcitability, explaining the elevated seizure incidence observed in BACE inhibitor clinical trials.\",\n      \"target_gene\": \"SCN8A\",\n      \"confidence_score\": 0.55,\n      \"novelty_score\": 0.6,\n      \"feasibility_score\": 0.5,\n      \"impact_score\": 0.7,\n      \"composite_score\": 0.59,\n      \"testable_prediction\": \"EEG monitoring in adult BACE1 inhibitor-treated mice will reveal increased seizure susceptibility and altered cortical network synchrony before measurable amyloid changes.\",\n      \"skeptic_concern\": \"Seizure risk may be secondary to compound-specific off-target effects rather than primary BACE1 inhibition; distinguishing mechanism from artifact requires isoform-selective inhibitors.\"\n    }\n  ],\n  \"consensus_points\": [\n    \"BACE1 normal physiological functions beyond APP processing are critical for predicting adverse effects of inhibitors\",\n    \"Clinical trial failures (cognitive worsening, seizures) implicate essential roles in myelination and neuronal function\",\n    \"Acute cognitive effects observed within weeks to months cannot be explained by developmental phenotypes alone\"\n  ],\n  \"dissent_points\": [\n    \"Skeptic argues the NRG1/node hypothesis conflates developmental arrest with adult maintenance requirements; expert contends this distinction may not matter for translational risk prediction\"\n  ],\n  \"debate_summary\": \"The debate converges on BACE1's essential physiological roles beyond amyloid processing, with NRG1 Type III cleavage at the Node of Ranvier emerging as the highest-priority translational concern given its direct relevance to cognitive worsening in trials. The central unresolved tension concerns whether BACE1 is required for ongoing nodal maintenance in adults or only during development, a mechanistic distinction with significant implications for therapeutic window and monitoring strategies.\"\n}",
      "tokens_used": "1029"
    }